| C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | 12-(3-adamantan-1-ylureido)dodecanoic acid affects the expression of TP73 mRNA | 19435785 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of TP73 mRNA | 15031205 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased phosphorylation of and results in increased activity of TP73 protein | 15031205 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | [arsenic trioxide co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] promotes the reaction [TP73 protein binds to TP53AIP1 promoter] | 15031205 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | [arsenic trioxide co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in increased activity of TP73 protein | 15031205 |
| C451219 | 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one | "2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one inhibits the reaction [TP53 protein mutant form binds to TP73 protein]" | 21647879 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide affects the expression of TP73 protein alternative form" | 16467208 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [arsenic trioxide results in increased expression of TP73 protein alternative form]" | 16467208 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased expression of TP73 mRNA" | 15031205 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide results in increased phosphorylation of and results in increased activity of TP73 protein" | 15031205 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "[arsenic trioxide co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] promotes the reaction [TP73 protein binds to TP53AIP1 promoter]" | 15031205 |
| C529061 | 2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone | "2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone inhibits the reaction [TP53 protein mutant form binds to TP73 protein]" | 18424558 |
| C529061 | 2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone | "TP53 protein mutant form affects the reaction [2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone results in increased expression of TP73 mRNA]" | 18424558 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B mRNA" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C006757 | 4-biphenylamine | 4-biphenylamine results in decreased expression of TP73 mRNA | 24857880 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of TP73 protein | 15607904 |
| D000249 | Adenosine Monophosphate | TP73 protein affects the abundance of Adenosine Monophosphate | 25554796 |
| D016604 | Aflatoxin B1 | [Zearalenone co-treated with Aflatoxin B1] results in increased expression of TP73 mRNA | 28965971 |
| D000393 | Air Pollutants | Air Pollutants results in decreased expression of TP73 mRNA | 23649983 |
| D047310 | Apigenin | Apigenin results in increased expression of TP73 protein | 19397994 |
| D001151 | Arsenic | Arsenic affects the methylation of TP73 gene | 25304211 |
| C006632 | arsenic trioxide | "2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [arsenic trioxide results in increased expression of TP73 protein alternative form]" | 16467208 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] promotes the reaction [TP73 protein binds to TP53AIP1 promoter] | 15031205 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in increased activity of TP73 protein | 15031205 |
| C006632 | arsenic trioxide | "[arsenic trioxide co-treated with 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide] promotes the reaction [TP73 protein binds to TP53AIP1 promoter]" | 15031205 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [EP300 protein binds to and results in increased acetylation of TP73 protein] | 15031205 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of TP73 mRNA | 19763917|2045855 |
| D001194 | Asbestos | Asbestos affects the localization of TP73 protein | 25466987 |
| D001280 | Atrazine | Atrazine results in increased expression of TP73 mRNA | 25929836 |
| D001374 | Azacitidine | TP73 protein promotes the reaction [Azacitidine results in increased expression of FAM129A mRNA] | 21245298 |
| D001374 | Azacitidine | TP73 protein promotes the reaction [Azacitidine results in increased expression of HMGA2 mRNA] | 21245298 |
| D001374 | Azacitidine | TP73 protein promotes the reaction [Azacitidine results in increased expression of KLF6 mRNA] | 21245298 |
| D053119 | Benzophenanthridines | Benzophenanthridines analog results in decreased expression of TP73 mRNA | 23117580 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the activity of TP73 protein | 20624995 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of TP73 mRNA | 20862736 |
| C095105 | bexarotene | bexarotene results in increased expression of TP73 protein | 19067706 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of TP73 mRNA | 25181051 |
| C546611 | brevetoxin 2 | brevetoxin 2 results in increased expression of TP73 mRNA | 20498034 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of TP73 mRNA | 27509014 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased methylation of TP73 gene | 27509014 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased activity of TP73 protein | 25446071 |
| D019256 | Cadmium Chloride | [Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene] | 25446071 |
| D019256 | Cadmium Chloride | Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]] | 25446071 |
| D002118 | Calcium | [Calcium co-treated with CAPN1 protein] results in increased degradation of TP73 protein modified form | 21516125 |
| C071482 | calpeptin | calpeptin inhibits the reaction [Cisplatin results in decreased expression of TP73 protein modified form] | 21516125 |
| C043561 | chrysin | chrysin results in increased expression of TP73 protein | 18331776|1939799 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased activity of TP73 protein | 25446071 |
| C018021 | cobaltous chloride | [cobaltous chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene] | 25446071 |
| D003300 | Copper | Copper results in decreased expression of TP73 mRNA | 16391388 |
| C000543 | cyclopiazonic acid | cyclopiazonic acid results in increased degradation of TP73 protein modified form | 21516125 |
| D016572 | Cyclosporine | Cyclosporine results in decreased methylation of TP73 promoter | 27989131 |
| C014347 | decitabine | decitabine results in decreased methylation of TP73 promoter | 19194470 |
| D003976 | Diazinon | Diazinon results in increased methylation of TP73 gene | 22964155 |
| D002945 | Cisplatin | calpeptin inhibits the reaction [Cisplatin results in decreased expression of TP73 protein modified form] | 21516125 |
| D002945 | Cisplatin | Cisplatin affects the localization of TP73 protein modified form | 21516125 |
| D002945 | Cisplatin | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS mRNA" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 mRNA" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B mRNA" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D002945 | Cisplatin | "[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein" | 21214929 |
| D002945 | Cisplatin | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| D002945 | Cisplatin | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| D002945 | Cisplatin | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| D002945 | Cisplatin | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| D002945 | Cisplatin | "[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D002945 | Cisplatin | [Cisplatin co-treated with TP73 protein] results in increased expression of BAX protein | 20100536 |
| D002945 | Cisplatin | [Cisplatin co-treated with TP73 protein] results in increased expression of CDKN1A protein | 20100536 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [[TP73 protein binds to GRAMD4 promoter] which results in increased expression of GRAMD4 mRNA] | 21127500 |
| D002945 | Cisplatin | Cisplatin promotes the reaction [[TP73 protein binds to IL4R intron] which results in increased expression of IL4R mRNA] | 14678968 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of TP73 mRNA | 21737676 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of TP73 protein modified form | 21516125 |
| D002945 | Cisplatin | Cisplatin results in increased activity of TP73 protein | 14678968 |
| D002945 | Cisplatin | Cisplatin results in increased expression of TP73 protein | 17076661|2065588 |
| D002945 | Cisplatin | Cisplatin results in increased localization of [PLK1 protein co-treated with TP73 protein] | 20655883 |
| D002945 | Cisplatin | PLK1 protein inhibits the reaction [Cisplatin results in increased expression of TP73 protein] | 20655883 |
| D002945 | Cisplatin | RELA protein mutant form inhibits the reaction [Cisplatin results in decreased expression of TP73 mRNA] | 21737676 |
| D002945 | Cisplatin | [Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein | 20686837 |
| D002945 | Cisplatin | [[Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein] which results in increased expression of BBC3 protein | 20686837 |
| D002945 | Cisplatin | [[Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein | 20686837 |
| D002945 | Cisplatin | TP73 mutant form inhibits the reaction [RELA promotes the reaction [Cisplatin results in increased expression of PMAIP1 mRNA]] | 21737676 |
| D002945 | Cisplatin | TP73 protein modified form promotes the reaction [Cisplatin results in increased expression of BBC3 protein] | 21516125 |
| D002945 | Cisplatin | TP73 protein modified form promotes the reaction [Cisplatin results in increased expression of PMAIP1 protein] | 21516125 |
| D002945 | Cisplatin | TP73 protein modified form results in increased susceptibility to Cisplatin | 21516125 |
| D002945 | Cisplatin | TP73 protein promotes the reaction [Cisplatin results in increased expression of GRAMD4 mRNA] | 21127500 |
| D002945 | Cisplatin | TP73 protein results in increased susceptibility to [Sirolimus co-treated with Cisplatin] | 20686837 |
| D002945 | Cisplatin | TP73 results in increased susceptibility to Cisplatin | 20100536 |
| D002945 | Cisplatin | wortmannin promotes the reaction [Cisplatin results in increased expression of TP73 protein] | 21214929 |
| D002945 | Cisplatin | "YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of and results in increased degradation of TP73 protein alternative form | 21837762 |
| D002945 | Cisplatin | Cisplatin results in increased expression of TP73 protein | 21837762 |
| D002117 | Calcitriol | [[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol | 17716971 |
| D004317 | Doxorubicin | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX mRNA" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS mRNA" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 mRNA" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B mRNA" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D004317 | Doxorubicin | "[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein" | 21214929 |
| D004317 | Doxorubicin | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein" | 21214929 |
| D004317 | Doxorubicin | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of BAX protein" | 21214929 |
| D004317 | Doxorubicin | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of FAS protein" | 21214929 |
| D004317 | Doxorubicin | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein" | 21214929 |
| D004317 | Doxorubicin | "[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [E2F1 protein binds to TP73 promoter] | 25124555 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [HDAC2 protein binds to TP73 promoter] | 25124555 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of TP73 mRNA | 17716971|2512455 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of TP73 protein | 17716971|2121492 |
| D004317 | Doxorubicin | E2F1 protein promotes the reaction [Doxorubicin results in increased expression of TP73 protein] | 25124555 |
| D004317 | Doxorubicin | SETD7 protein inhibits the reaction [Doxorubicin results in increased expression of TP73 mRNA] | 25124555 |
| D004317 | Doxorubicin | SETD7 protein inhibits the reaction [Doxorubicin results in increased expression of TP73 protein] | 25124555 |
| D004317 | Doxorubicin | SETD7 protein promotes the reaction [Doxorubicin promotes the reaction [E2F1 protein binds to TP73 promoter]] | 25124555 |
| D004317 | Doxorubicin | SETD7 protein promotes the reaction [Doxorubicin promotes the reaction [HDAC2 protein binds to TP73 promoter]] | 25124555 |
| D004317 | Doxorubicin | wortmannin promotes the reaction [Doxorubicin results in increased expression of TP73 protein] | 21214929 |
| D004317 | Doxorubicin | "YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D004492 | Edetic Acid | Edetic Acid inhibits the reaction [[Cadmium Chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene]] | 25446071 |
| D005047 | Etoposide | Etoposide results in increased expression of TP73 mRNA | 17716971 |
| D005047 | Etoposide | Etoposide results in increased expression of TP73 protein | 17716971|2180144 |
| D005047 | Etoposide | [[Etoposide results in increased expression of TP73 protein] which results in increased expression of VDR protein] which results in increased susceptibility to Calcitriol | 17716971 |
| D005047 | Etoposide | TP73 mutant form inhibits the reaction [Etoposide results in increased activity of CASP3 protein] | 21801448 |
| D005047 | Etoposide | TP73 mutant form inhibits the reaction [Etoposide results in increased activity of CASP7 protein] | 21801448 |
| D005047 | Etoposide | TP73 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP3 protein] | 21801448 |
| D005047 | Etoposide | TP73 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP8 protein] | 21801448 |
| D005047 | Etoposide | TP73 protein affects the reaction [Etoposide results in increased expression of VDR mRNA] | 17716971 |
| D015025 | Zearalenone | [Zearalenone co-treated with Aflatoxin B1] results in increased expression of TP73 mRNA | 28965971 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in decreased expression of TP73 mRNA | 22213190 |
| D005472 | Fluorouracil | TP73 protein affects the susceptibility to Fluorouracil | 18714155 |
| D005472 | Fluorouracil | TP73 protein promotes the reaction [Fluorouracil results in increased expression of GRAMD4 mRNA] | 21127500 |
| C039281 | furan | furan results in decreased expression of TP73 mRNA | 25539665 |
| D007291 | Inosine Monophosphate | TP73 protein affects the abundance of Inosine Monophosphate | 25554796 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of TP73 mRNA | 24796395 |
| C006552 | kaempferol | kaempferol results in increased expression of TP73 protein | 18331776|1939799 |
| D007654 | Ketoconazole | Ketoconazole results in decreased expression of TP73 mRNA | 25808816 |
| D047311 | Luteolin | Luteolin results in increased expression of TP73 protein | 18331776|1939799 |
| C025340 | manganese chloride | manganese chloride results in decreased expression of TP73 mRNA | 27107493 |
| C025340 | manganese chloride | manganese chloride results in decreased expression of TP73 protein modified form | 27107493 |
| C025340 | manganese chloride | TP73 protein modified form results in decreased susceptibility to manganese chloride | 27107493 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased expression of TP73 mRNA | 23649840 |
| D015655 | 1-Methyl-4-phenylpyridinium | U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of TP73 mRNA] | 12710931 |
| C040015 | myricetin | myricetin results in increased expression of TP73 protein | 19397994 |
| C005246 | myristicin | myristicin results in decreased expression of TP73 mRNA | 24792648 |
| C022838 | nickel chloride | nickel chloride results in decreased activity of TP73 protein | 25446071 |
| C022838 | nickel chloride | [nickel chloride results in decreased activity of TP73 protein] inhibits the reaction [TP73 protein binds to TP53 gene] | 25446071 |
| C022838 | nickel chloride | nickel chloride results in increased phosphorylation of TP73 protein | 21466819 |
| C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of TP73 protein | 14587038 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of TP73 mRNA" | 18778698 |
| C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "TP53 mutant form inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of TP73 mRNA]" | 18778698 |
| C482205 | nutlin 3 | nutlin 3 inhibits the reaction [TP73 binds to MDM2] | 20422343 |
| C016340 | o,p'-DDT | "o,p'-DDT analog results in decreased expression of TP73 mRNA" | 22937105 |
| C016340 | o,p'-DDT | "o,p'-DDT results in increased expression of TP73 mRNA" | 22937105 |
| C046012 | pentanal | pentanal results in increased expression of TP73 mRNA | 26079696 |
| C030090 | phosphoramide mustard | phosphoramide mustard results in increased expression of TP73 mRNA | 26708502 |
| C030090 | phosphoramide mustard | phosphoramide mustard results in increased expression of TP73 protein | 26708502 |
| C121565 | pifithrin | pifithrin results in decreased activity of TP73 protein | 18418056 |
| C498077 | piperlonguminine | piperlonguminine inhibits the reaction [TP73 protein binds to XPO1 protein] | 26026911 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of TP73 mRNA | 23557933 |
| D011794 | Quercetin | Quercetin results in increased expression of TP73 protein | 18331776|1939799 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride results in decreased expression of TP73 mRNA | 19429434 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of TP73 protein | 11517458 |
| C059514 | resveratrol | resveratrol results in increased expression of TP73 mRNA | 18347188 |
| C059514 | resveratrol | resveratrol results in increased expression of TP73 protein | 18347188 |
| D012176 | Retinoids | Retinoids results in increased expression of TP73 protein | 19067706 |
| D020123 | Sirolimus | [Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein | 20686837 |
| D020123 | Sirolimus | [[Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein] which results in increased expression of BBC3 protein | 20686837 |
| D020123 | Sirolimus | [[Sirolimus co-treated with Cisplatin] results in increased expression of TP73 protein] which results in increased expression of PMAIP1 protein | 20686837 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein affects the activity of HEN1 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein affects the activity of HOXA9 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein affects the activity of TAL1 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein affects the activity of ZIC2 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of ACER2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of JMY mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of MIR181A2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of NR1H4 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of RPL7P26 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of SCD mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of SERPINE1 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in decreased expression of YPEL1 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of BTBD11 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of C9ORF3 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of CAV3 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of CCNG2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of CHRNB3 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of DEPDC6 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of FAXDC2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of FBXO32 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of FGF7 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of FOLR1 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of FTL mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of ING4 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MBNL2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MTURN mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MYLK mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of MYOF mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of NMU mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of OXA1L mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of SEMA3C mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of SIRT2 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of SMIM14 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of STARD10 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of SYT1 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of TMEM14C mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus inhibits the reaction [TP73 protein results in increased expression of ZNRD1 mRNA] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein affects the activity of GCM2 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein affects the activity of PAX8 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein affects the activity of REST protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein affects the activity of TEAD1 protein] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein binds to MDM2 promoter] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein binds to RPS27L promoter] | 21245298 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [TP73 protein binds to RRAD promoter] | 21245298 |
| D020123 | Sirolimus | Sirolimus results in increased expression of TP73 protein | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR151 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR190A mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR29C mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR324 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR379 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR433 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR503 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR508 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR650 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR654 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR758 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein promotes the reaction [Sirolimus results in increased expression of MIR760 mRNA] | 21245298 |
| D020123 | Sirolimus | TP73 protein results in increased susceptibility to [Sirolimus co-treated with Cisplatin] | 20686837 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of TP73 mRNA | 29319823 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of TP73 gene | 28589171 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of TP73 mRNA | 28595984 |
| C525423 | SRT2183 | SRT2183 results in increased expression of TP73 mRNA | 23681230 |
| C113580 | U 0126 | U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of TP73 mRNA] | 12710931 |
| D014520 | Urethane | Urethane results in decreased expression of TP73 mRNA | 28818685 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of TP73 gene | 28853863|2915479 |
| D014800 | Vitallium | Vitallium analog results in increased expression of TP73 mRNA | 23825117 |
| C009687 | wortmannin | wortmannin promotes the reaction [Cisplatin results in increased expression of TP73 protein] | 21214929 |
| C009687 | wortmannin | wortmannin promotes the reaction [Doxorubicin results in increased expression of TP73 protein] | 21214929 |
| D015032 | Zinc | Zinc binds to and affects the folding of and affects the activity of TP73 protein | 17170001 |
| D015032 | Zinc | Zinc deficiency results in decreased expression of TP73 mRNA | 18356318 |